Ebola -- Nigeria
The proposed VSV-ZEBOV program will not involve the whole population, but will be a ring vaccination, in which immediate contacts of patients infected with Ebola are immunized. That was the approach used in the phase III study of VSV-ZEBOV, which took place in Guinea during the 2013-2016 Ebola epidemic. That trial, published in December 2016, showed the vaccine to be 100 percent effective, with no one who received VSV-ZEBOV contracting the virus. (See BioWorld Today, 27 Dec 2016; .)
Salama
Read more about it at HealthMap Global Disease Alerts via http://bit.ly/2rF810t
No comments:
Post a Comment